The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
Open accessAbstract
Recent studies have implicated physiological and metabolic abnormalities in autism spectrum disorders (ASD) and other psychiatric disorders, particularly immune dysregulation or inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures ('four major areas'). The aim of this study was to determine trends in the literature on these topics with respect to ASD. A comprehensive literature search from 1971 to 2010 was performed in these four major areas in ASD with three objectives. First, publications were divided by several criteria, including whether or not they implicated an association between the physiological abnormality and ASD. A large percentage of publications implicated an association between ASD and immune dysregulation/inflammation (416 out of 437 publications, 95%), oxidative stress (all 115), mitochondrial dysfunction (145 of 153, 95%) and toxicant exposures (170 of 190, 89%). Second, the strength of evidence for publications in each area was computed using a validated scale. The strongest evidence was for immune dysregulation/inflammation and oxidative stress, followed by toxicant exposures and mitochondrial dysfunction. In all areas, at least 45% of the publications were rated as providing strong evidence for an association between the physiological abnormalities and ASD. Third, the time trends in the four major areas were compared with trends in neuroimaging, neuropathology, theory of mind and genetics ('four comparison areas'). The number of publications per 5-year block in all eight areas was calculated in order to identify significant changes in trends. Prior to 1986, only 12 publications were identified in the four major areas and 51 in the four comparison areas (42 for genetics). For each 5-year period, the total number of publications in the eight combined areas increased progressively. Most publications (552 of 895, 62%) in the four major areas were published in the last 5 years (2006-2010). Evaluation of trends between the four major areas and the four comparison areas demonstrated that the largest relative growth was in immune dysregulation/inflammation, oxidative stress, toxicant exposures, genetics and neuroimaging. Research on mitochondrial dysfunction started growing in the last 5 years. Theory of mind and neuropathology research has declined in recent years. Although most publications implicated an association between the four major areas and ASD, publication bias may have led to an overestimation of this association. Further research into these physiological areas may provide insight into general or subset-specific processes that could contribute to the development of ASD and other psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Diabetes, oxidative stress, and antioxidants: A review
Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10058 · Cited by 3,124
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Developmental neurotoxicity of industrial chemicals
Grandjean, P., & Landrigan, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69665-7 · Cited by 1,984
Role of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
Calderón-Garcidueñas, L., Solt, A. C., Henríquez-Roldán, C., Torres-Jardón, R., Nuse, B., Herritt, L., Villarreal-Calderón, R., Osnaya, N., Stone, I., García, R., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623307313011 · Cited by 937
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 907
Self-citationBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872
TOXIC AND ESSENTIAL METAL INTERACTIONS
Goyer, R. A. (1997) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.17.1.37 · Cited by 791
Elevated immune response in the brain of autistic patients
Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., & Malik, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.002 · Cited by 786
Rice, C. (2009) · PsycEXTRA Dataset · doi:10.1037/e562722010-001 · Cited by 759
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
James, S. J., Melnyk, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., Cutler, P., Bock, K., Boris, M., Bradstreet, J. J., et al. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30366 · Cited by 604
Brain Inflammation and Alzheimer's-Like Pathology in Individuals Exposed to Severe Air Pollution
Calderón-Garcidueñas, L., Reed, W., Maronpot, R. R., Henriquez-Roldán, C., Delgado-Chavez, R., Calderón-Garcidueñas, A., Dragustinovis, I., Franco-Lira, M., Aragón-Flores, M., Solt, A. C., et al. (2004) · Toxicologic Pathology · doi:10.1080/01926230490520232 · Cited by 583
Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children
Braun, J. M., Kahn, R. S., Froehlich, T., Auinger, P., & Lanphear, B. P. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9478 · Cited by 573
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R. A., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 559
Oxidative stress markers in bipolar disorder: A meta-analysis
Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526
Immunity, neuroglia and neuroinflammation in autism
Pardo, C. A., Vargas, D. L., & Zimmerman, A. W. (2005) · International Review of Psychiatry · doi:10.1080/02646830500381930 · Cited by 460
Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides
Bouchard, M. F., Bellinger, D. C., Wright, R. O., & Weisskopf, M. G. (2010) · Pediatrics · doi:10.1542/peds.2009-3058 · Cited by 457
Roberts, E. M., English, P. B., Grether, J. K., Windham, G. C., Somberg, L., & Wolff, C. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10168 · Cited by 442
Rao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432
Windham, G. C., Zhang, L., Gunier, R., Croen, L. A., & Grether, J. K. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9120 · Cited by 424
(2009) · PubMed · Cited by 409
Neuroinflammation in Alzheimer's disease and prion disease
Eikelenboom, P., Bate, C., Van Gool, W. A., Hoozemans, J. J. M., Rozemuller, J. M., Veerhuis, R., & Williams, A. (2002) · Glia · doi:10.1002/glia.10146 · Cited by 405
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399
Antioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368
Hiura, T. S., Kaszubowski, M. P., Li, N., & Nel, A. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5582 · Cited by 334
Mitochondrial involvement in psychiatric disorders
Shao, L., Martin, M. V., Watson, S. J., Schatzberg, A., Akil, H., Myers, R. M., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2008) · Annals of Medicine · doi:10.1080/07853890801923753 · Cited by 305
Nigg, J. T., Knottnerus, G. M., Martel, M. M., Nikolas, M., Cavanagh, K., Karmaus, W., & Rappley, M. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.013 · Cited by 284
Flora, S. J. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03157.x · Cited by 273
Mitochondrial Disease: A Practical Approach for Primary Care Physicians
Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., & Cohen, B. H. (2007) · Pediatrics · doi:10.1542/peds.2007-0391 · Cited by 273
Autism spectrum disorders: Concurrent clinical disorders
Ming, X., Brimacombe, M., Chaaban, J., Zimmerman-Bier, B., & Wagner, G. C. (2008) · Journal of Child Neurology · doi:10.1177/0883073807307102 · Cited by 266
Nitrative and Oxidative Stress in Toxicology and Disease
Roberts, R. A., Laskin, D. L., Smith, C. V., Robertson, F. M., Allen, E. M. G., Doorn, J. A., & Slikker, W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp179 · Cited by 256
James, S. J., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., Pavliv, O., Hubanks, A., & Gaylor, D. W. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26615 · Cited by 241
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234
Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children
Al-Gadani, Y., El-Ansary, A., Attas, O., & Al-Ayadhi, L. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.03.011 · Cited by 217
FRYE, R. E., & ROSSIGNOL, D. A. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212f16b · Cited by 217
Self-citationOxidative stress in neurotoxic effects of methylmercury poisoning.
Yee, S., & Choi, B. (1996) · PubMed · Cited by 214
Oxidative Stress in Hypertension
de Champlain, J., Wu, R., Girouard, H., Karas, M., EL Midaoui, A., Laplante, M., & Wu, L. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031904 · Cited by 208
The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders
Faber, S., Zinn, G. M., Kern II, J. C., & Skip Kingston, H. M. (2009) · Biomarkers · doi:10.1080/13547500902783747 · Cited by 199
Biomarkers of environmental toxicity and susceptibility in autism
Geier, D. A., Kern, J. K., Garver, C. R., Adams, J. B., Audhya, T., Nataf, R., & Geier, M. R. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.021 · Cited by 196
Genetics evaluation for the etiologic diagnosis of autism spectrum disorders
Schaefer, G. B., & Mendelsohn, N. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31815efdd7 · Cited by 173
A preliminary trial of ascorbic acid as supplemental therapy for autism
Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90058-z · Cited by 168
A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders
Geier, D. A., Kern, J. K., Garver, C. R., Adams, J. B., Audhya, T., & Geier, M. R. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9782-x · Cited by 160
Gupta, S., Aggarwal, S., & Heads, C. (1996) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172828 · Cited by 156
Proximity to point sources of environmental mercury release as a predictor of autism prevalence
Palmer, R. F., Stephen Blanchard, B., & Wood, R. G. (2008) · Health & Place · doi:10.1016/j.healthplace.2008.02.001 · Cited by 149
Johnson, B. A., Ait‐Daoud, N., Elkashef, A. M., Smith, E. V., Kahn, R., Vocci, F., Li, S.-H., Bloch, D. A., & the Methamphetamine Study Group (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007778 · Cited by 133
Shenker, B. J., Guo, T. L., O‐Sullivan, I., & Shapiro, I. M. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8652 · Cited by 128
Effect of pioglitazone treatment on behavioral symptoms in autistic children.
Boris, M., Kaiser, C. C., Goldblatt, A., Elice, M. W., Edelson, S. M., Adams, J. B., & Feinstein, D. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-3 · Cited by 123
Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report
Frey, B. N., Andreazza, A. C., Kunz, M., Gomes, F. A., Quevedo, J., Salvador, M., Gonçalves, C. A., & Kapczinski, F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.011 · Cited by 120
A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders
Bradstreet, J., Kartzinel, J. J., & Geier, M. R. (2003) · Cited by 117
Bertoglio, K., James, S. J., Deprey, L., Brule, N., & Hendren, R. L. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0177 · Cited by 114
Akhondzadeh, S., Fallah, J., Mohammadi, M.-R., Imani, R., Mohammadi, M., Salehi, B., Ghanizadeh, A. J., Raznahan, M., Mohebbi-Rasa, S., Rezazadeh, S., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.012 · Cited by 114
Bouvard, M. P., Leboyer, M., Launay, J.-M., Recasens, C., Plumet, M.-H., Waller-Perotte, D., Tabuteau, F., Bondoux, D., Dugas, M., Lensing, P., et al. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02601-r · Cited by 112
Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia.
Opler, M. G. A., Brown, A. S., Graziano, J. H., Desai, M., Zheng, W., Schaefer, C. A., Factor-Litvak, P., & Susser, E. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6777 · Cited by 111
Rossignol, D. A., Rossignol, L. W., James, S. J., Melnyk, S., & Mumper, E. A. (2007) · BMC Pediatrics · doi:10.1186/1471-2431-7-36 · Cited by 110
Self-citationA Prospective Study of Mercury Toxicity Biomarkers in Autistic Spectrum Disorders∗
Geier, D. A., & Geier, M. R. (2007) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390701457712 · Cited by 100
The role of mitochondrial dysfunction in psychiatric disease
Scaglia, F. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.115 · Cited by 98
Rossignol, D. A., Rossignol, L. W., Smith, S. A., Schneider, C., Logerquist, S., Usman, A., Neubrander, J., Madren, E. M., Hintz, G., Grushkin, B., et al. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-21 · Cited by 98
Self-citationCase Study: Corticosteroid Treatment of Language Regression in Pervasive Developmental Disorder
Stefanatos, G. A., Grover, W. D., & Geller, E. T. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199508000-00022 · Cited by 97
Mercury induces inflammatory mediator release from human mast cells
Kempuraj, D., Asadi, S., Zhang, B., Manola, A., Hogan, J. A., Peterson, E. L., & Theoharides, T. C. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-20 · Cited by 96
Mitochondrial DNA (mtDNA) and schizophrenia
Vergé, B., Alonso, Y., Valero, J., Miralles, C., Vilella, E., & Martorell, L. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.08.008 · Cited by 94
Flora, S. J. S., Pande, M., Kannan, G. M., & Mehta, A. K. (2004) · PubMed · Cited by 93
Chemically Diverse Toxicants Converge on Fyn and c-Cbl to Disrupt Precursor Cell Function
Li, Z., Dong, T., Pröschel, C., & Noble, M. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050035 · Cited by 92
Kleinman, J. E., Law, A. J., Lipska, B. K., Hyde, T. M., Ellis, J. K., Harrison, P. J., & Weinberger, D. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.032 · Cited by 89
Organic mercury compounds and autoimmunity
Havarinasab, S., & Hultman, P. A. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.12.001 · Cited by 88
Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study.
Lonsdale, D., Shamberger, R. J., & AUDHYA, T. K. (2002) · PubMed · Cited by 85
Bhadauria, S., & Flora, S. J. S. (2006) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0135-8 · Cited by 84
Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes
Yamano, T., & Morita, S. (1993) · Archives of Environmental Contamination and Toxicology · doi:10.1007/bf00212141 · Cited by 83
Psychiatric Disorders among Egyptian Pesticide Applicators and Formulators
Amr, M. M., Halim, Z., & Moussa, S. S. (1997) · Environmental Research · doi:10.1006/enrs.1997.3744 · Cited by 83
Brady, B. M. (1998) · Psychiatric Services · doi:10.1176/ps.49.8.1103-a · Cited by 83
Mailloux, R. J., Lemire, J. A., & Appanna, V. D. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000107546 · Cited by 82
Metabolic biomarkers related to energy metabolism in Saudi autistic children
Al-Mosalem, O. A., El-Ansary, A. K., Al-Attas, O., & AL-Ayadhi, L. Y. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.04.006 · Cited by 81
Patel, K., & Curtis, L. T. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.0611 · Cited by 78
Adams, J. B., Baral, M., Geis, E., Mitchell, J., Ingram, J., Hensley, A., Zappia, I., Newmark, S. C., Gehn, E., Rubin, R. A., et al. (2009) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-9-16 · Cited by 78
Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes II
Yamano, T., & Morita, S. (1995) · Archives of Environmental Contamination and Toxicology · doi:10.1007/bf00213961 · Cited by 73
Bradstreet, J. J., Smith, S. A., Baral, M., & Rossignol, D. A. (2010) · PubMed · Cited by 71
Self-citationFowler, B. A., & Woods, J. S. (1977) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(77)90010-7 · Cited by 69
Evidence of Mitochondrial Dysfunction in Autism and Implications for Treatment
Rossignol, D. A., & Bradstreet, J. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.208.217 · Cited by 69
Self-citationImmunological Treatments for Autism
Gupta, S. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005568027292 · Cited by 66
Mercury and nickel allergy: risk factors in fatigue and autoimmunity.
Sterzl, I., Procházková, J., Hrdá, P., et al. (1999) · PubMed · Cited by 64
Wong, P. W., Garcia, E. F., & Pessah, I. N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00022.x · Cited by 62
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome
Shenoy, S. M., Arnold, S., & Chatila, T. A. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105355 · Cited by 60
Anderson, M. P., Hooker, B. S., & Herbert, M. R. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.167.176 · Cited by 54
Pourahmad, J., Mihajlovic, A., & O’Brien, P. J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_38 · Cited by 47
Scifo, R., Cioni, M., Nicolosi, A., Batticane, N., Tirolo, C., Testa, N., Quattropani, M. C. A., Morale, M. C., Gallo, F., & Marchetti, B. (1996) · PubMed · Cited by 40
Bradstreet, J. J., Smith, S. A., Granpeesheh, D., El-Dahr, J. M., & Rossignol, D. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.015 · Cited by 40
Self-citationDialysable lymphocyte extract (DLyE) in infantile onset autism: A pilot study
Fudenberg, H. H. (1996) · Biotherapy · doi:10.1007/bf02628672 · Cited by 36
Neuroinflammation in Alzheimer's Disease and Major Depression
Dobos, N., Korf, J., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.023 · Cited by 35
Toxicity biomarkers in autism spectrum disorder: A blinded study of urinary porphyrins
Kern, J. K., Geier, D. A., Adams, J. B., Mehta, J. A., Grannemann, B. D., & Geier, M. R. (2010) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03196.x · Cited by 34
Mitochondrial DNA deletion mutations in patients with neuropsychiatric symptoms
Kato, M., Nakamura, M., Ichiba, M., Tomiyasu, A., Shimo, H., Higuchi, I., Ueno, S., & Sano, A. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.12.013 · Cited by 32
Adams, J. B., Baral, M., Geis, E., Mitchell, J., Ingram, J., Hensley, A., Zappia, I., Newmark, S. C., Gehn, E., Rubin, R. A., et al. (2009) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-9-17 · Cited by 32
Pentoxifylline: Brief Review and Rationale for Its Possible Use in the Treatment of Autism
Gupta, S., Rimland, B., & Shilling, P. D. (1996) · Journal of Child Neurology · doi:10.1177/088307389601100622 · Cited by 27
Improving the Prediction of Response to Therapy in Autism
Bent, S., & Hendren, R. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.011 · Cited by 25
Improvement in children with autism treated with intravenous gamma globulin
Boris, M., Goldblatt, A., & Edelson, S. M. (2005) · Journal of Nutritional & Environmental Medicine · doi:10.1080/13590840600681827 · Cited by 24
Komori, H., Matsuishi, T., Yamada, S., Yamashita, Y., Ohtaki, E., & Kato, H. (1995) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02178503 · Cited by 21
Burke, M. G., & Miller, M. D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2256 · Cited by 20
Treatment of children with autism with intravenous immunoglobulin.
Gupta, S. (1999) · PubMed · Cited by 19
Mechanistic biomarkers for autism treatment
Hendren, R. L., Bertoglio, K., Ashwood, P., & Sharp, F. R. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.06.032 · Cited by 15
Cited by
Sex/Gender Differences and Autism: Setting the Scene for Future Research
Lai, M.-C., Lombardo, M. V., Auyeung, B., Chakrabarti, B., & Baron-Cohen, S. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.003 · Cited by 1,120
Consensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Self-citationThe Gut Microbiota and Autism Spectrum Disorders
Li, Q., Han, Y., Dy, A. B. C., & Hagerman, R. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00120 · Cited by 462
Environmental toxicants and autism spectrum disorders: a systematic review
Rossignol, D. A., Genuis, S. J., & Frye, R. E. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.4 · Cited by 458
Self-citation
Metadata
- Authors
- Rossignol, D. A., & Frye, R. E.
- Venue
- Molecular Psychiatry
- Published
- 2011-12-06
- Volume
- 17
- Issue
- 4
- Pages
- 389-401
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2156464405
- Cited by
- 543
- References
- 105
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.